{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T21:07:01Z","timestamp":1779224821995,"version":"3.51.4"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,19]]},"DOI":"10.7759\/cureus.109221","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T20:30:35Z","timestamp":1779222635000},"source":"Crossref","is-referenced-by-count":0,"title":["Non-traumatic Iliacus Muscle Hematoma During Anticoagulation Bridging in a Patient With Active Malignancy: A Case of Multifactorial Bleeding Risk"],"prefix":"10.7759","author":[{"given":"Samuel","family":"Fernandez Perez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando A","family":"Sosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reubyn William","family":"Chong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-021-06598-8","article-title":"Incidence, risk factors, and management of bleeding in patients receiving anticoagulants for the treatment of cancer-associated thrombosis","volume":"30","author":"Frere C","year":"2022","unstructured":"Frere C, Font C, Esposito F, Crichi B, Girard P, Janus N. Incidence, risk factors, and management of bleeding in patients receiving anticoagulants for the treatment of cancer-associated thrombosis. Support Care Cancer. 2022, 30:2919-2931. 10.1007\/s00520-021-06598-8","journal-title":"Support Care Cancer"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25494","article-title":"Bleeding incidence and risk factors among cancer patients treated with anticoagulation","volume":"94","author":"Angelini DE","year":"2019","unstructured":"Angelini DE, Radivoyevitch T, McCrae KR, Khorana AA. Bleeding incidence and risk factors among cancer patients treated with anticoagulation. Am J Hematol. 2019, 94:780-785. 10.1002\/ajh.25494","journal-title":"Am J Hematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.03.011","article-title":"2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"70","author":"Nishimura RA","year":"2017","unstructured":"Nishimura RA, Otto CM, Bonow RO, et al.. 2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017, 70:252-289. 10.1016\/j.jacc.2017.03.011","journal-title":"J Am Coll Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou MG","year":"2019","unstructured":"Tektonidou MG, Andreoli L, Limper M, et al.. EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis. 2019, 78:1296-1304. 10.1136\/annrheumdis-2019-215213","journal-title":"Ann Rheum Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2020.12.022","article-title":"Acute, major muscular hematoma associated with antithrombotic agents: a multicenter real-world cohort","volume":"199","author":"Bouget J","year":"2021","unstructured":"Bouget J, Huet MC, Roy PM, Viglino D, Lacut K, Pavageau L, Oger E. Acute, major muscular hematoma associated with antithrombotic agents: a multicenter real-world cohort. Thromb Res. 2021, 199:54-58. 10.1016\/j.thromres.2020.12.022","journal-title":"Thromb Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0211680","article-title":"Spontaneous ilio-psoas hematomas complicating intensive care unit hospitalizations","volume":"14","author":"Artzner T","year":"2019","unstructured":"Artzner T, Clere-Jehl R, Schenck M, et al.. Spontaneous ilio-psoas hematomas complicating intensive care unit hospitalizations. PLoS One. 2019, 14:e0211680. 10.1371\/journal.pone.0211680","journal-title":"PLoS One"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.injury.2022.11.057","article-title":"The epidemiology and management of iliopsoas hematoma with femoral nerve palsy: a descriptive systematic review of 174 cases","volume":"54","author":"Guild TT","year":"2023","unstructured":"Guild TT, Crawford AM, Striano BM, Mortensen S, Wixted JJ. The epidemiology and management of iliopsoas hematoma with femoral nerve palsy: a descriptive systematic review of 174 cases. Injury. 2023, 54:280-287. 10.1016\/j.injury.2022.11.057","journal-title":"Injury"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1378\/chest.121.1.19","article-title":"Clinical observations with the amiodarone\/warfarin interaction: dosing relationships with long-term therapy","volume":"121","author":"Sanoski CA","year":"2002","unstructured":"Sanoski CA, Bauman JL. Clinical observations with the amiodarone\/warfarin interaction: dosing relationships with long-term therapy. Chest. 2002, 121:19-23. 10.1378\/chest.121.1.19","journal-title":"Chest"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2021.04.008","article-title":"Spontaneous iliopsoas muscle hemorrhage-predictors of associated mortality","volume":"29","author":"Decker JA","year":"2022","unstructured":"Decker JA, Brill LM, Orlowski U, et al.. Spontaneous iliopsoas muscle hemorrhage-predictors of associated mortality. Acad Radiol. 2022, 29:536-542. 10.1016\/j.acra.2021.04.008","journal-title":"Acad Radiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2025000703","article-title":"Anticoagulation in malignancy: the patient who bleeds and clots simultaneously","volume":"2025","author":"Kapoor S","year":"2025","unstructured":"Kapoor S, Peseski AM, Ortel TL. Anticoagulation in malignancy: the patient who bleeds and clots simultaneously. Hematology Am Soc Hematol Educ Program. 2025, 2025:176-182. 10.1182\/hematology.2025000703","journal-title":"Hematology Am Soc Hematol Educ Program"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/493691-non-traumatic-iliacus-muscle-hematoma-during-anticoagulation-bridging-in-a-patient-with-active-malignancy-a-case-of-multifactorial-bleeding-risk","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T20:30:36Z","timestamp":1779222636000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/493691-non-traumatic-iliacus-muscle-hematoma-during-anticoagulation-bridging-in-a-patient-with-active-malignancy-a-case-of-multifactorial-bleeding-risk"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.109221","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,19]]}}}